|
Volumn 114, Issue 2, 2001, Pages 342-348
|
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): Results of a phase II study of the German CLL Study Group
|
Author keywords
CLL; Cyclophosphamide; Fludarabine; Phase II; Response
|
Indexed keywords
CYCLOPHOSPHAMIDE;
FLUDARABINE;
ADULT;
AGED;
ANEMIA;
ARTICLE;
B CELL LEUKEMIA;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RECURRENCE;
CANCER STAGING;
CHRONIC LYMPHATIC LEUKEMIA;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG FATALITY;
DRUG INDUCED DISEASE;
DRUG RESPONSE;
FEMALE;
GERMANY;
HUMAN;
INFECTION;
LEUKEMIA REMISSION;
MALE;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOPHOSPHAMIDE;
FEMALE;
HUMANS;
LEUKEMIA, LYMPHOCYTIC, CHRONIC;
LEUKOPENIA;
MALE;
MIDDLE AGED;
NEUTROPENIA;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
VIDARABINE;
|
EID: 0034893776
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2141.2001.02959.x Document Type: Article |
Times cited : (118)
|
References (19)
|